Shanghai Institute of Materia Medica
Profile
| Official Chinese name | 中国科学院上海药物研究所 |
|---|---|
| Official English name | Shanghai Institute of Materia Medica, Chinese Academy of Sciences |
| Chinese aliases | 上海药物所, 国立北平研究院药物研究所 |
| English aliases | Institute of Materia Medica of the National Peking Academy of Sciences |
| Acronyms | SIMM |
| Research fields | Developing new drugs for the treatment of malignant tumours, cardiovascular and cerebrovascular diseases, neuropsychiatric diseases, metabolic diseases, autoimmune and infectious diseases |
| Total employee count | Over 1,300 (as of 24 November 2025) |
Summary
Shanghai Institute of Materia Medica is categorised as a Limited Defence Partner based on the following indicators:
- Defence advisor
- 1 indicator
- Defence award
- 1 indicators
- Defence funding
- 3 indicators
- Defence laboratory
- 1 indicators
- Military-technology patent
- 1 indicators
- Research collaboration with defence entities
- 3 indicators
A limited defence partner contributes to the development of China’s defence capabilities in ways that are limited in time, frequency, scope or scale. Evidence indicates that participation has either ceased or if it persists, it is narrow in scope, not institutionalised and occurs through isolated or infrequent activities led by individual researchers, rather than through sustained programmes or organisational commitments.
Rules-based framework
| Rule | Resulting category |
|---|---|
| Two or more indicators = 4 | Core defence partner |
| One indicator = 4 and two indicators = 3 or Three or more indicators = 3 | Regular defence partner |
| One indicator = 4 and one indicator = 3 and all other indicators = 1 or 2 or Two indicators = 3 and all other indicators = 1 or 2 | Limited defence partner |
| All indicators between 0 and 2 | Civilian institute |
| Three or more indicators = 0 | Insufficient data |
Note: All indicators operate on a 0 to 4 scale. There are a total of six indicators.
For more information on the graded scales see the user guide.
Defence advisory roles
Members of the leadership of the Shanghai Institute of Material Medica have almost certainly not served on defence-related expert committees. As the data reviewed are complete, up-to-date and cover all members of the leadership team, this assessment is made with high confidence.
Defence awards
Available information indicates that only one researcher with links to the Shanghai Institute of Materia Medica has received a defence award: a Commemorative Medal for the 70th Anniversary of the Founding of the People's Republic of China.[1]
This award was granted to a former director of the institute in 2019.[2] However, according to available data their affiliated with the Shanghai Institute of Materia Medica ended when they stepped down as director in 2014, and no further information about their activities in 2019 could be found.[3] As a result, our analysis was unable to confidently connect this award to work carried out at the Shanghai Institute of Materia Medica.
While at least one researcher with links to the Shanghai Institute of Materia Medica has received a defence award, our analysis was unable to determine whether awards had been granted in recent years or in connection to work conducted at the institute. Because the underlying data are somewhat outdated, the assessment is made with medium confidence, particularly with respect to any more recent awards.
Defence funding
Between 2021 and 2025, researchers from the Shanghai Institute of Materia Medica authored ten publications funded by Chinese defence entities, placing the institute in the 29th percentile among the CAS institutes included in this analysis. Of the 4,584 authors affiliated with the Shanghai Institute of Materia Medica who published during this period, 47 (1 per cent) had at least one defence-funded publication. However, it is not possible to attribute specific funding to individual researchers based solely on publication data.
Defence laboratories
No publicly available information suggests that this institute hosts or is affiliated with any known defence laboratories. The Chinese language laboratory websites do not mention any links or references to defence-related activities.
Military-technology patents
Between 2021 and 2025, the Shanghai Institute of Materia Medica was not granted any military-technology patents. This places it at the very bottom (0th percentile) among the CAS institutes included in this analysis. No inventors from the Shanghai Institute of Materia Medica were listed on any military-technology patents during this period.
Research collaboration with defence entities
Between 2021 and 2025, researchers from the Shanghai Institute of Materia Medica co-authored 229 publications with at least one Chinese defence entity, placing the institute in the 31st percentile among the CAS institutes included in this analysis.
These collaborations include 33 publications with PLA academic institutions, 155 with defence laboratories, 14 with military hospitals, 31 with members of the Seven Sons of National Defence, 3 with members of the Seven Sons of Ordnance Industry and 2 with defence conglomerates.
Of the 4,584 authors affiliated with the Shanghai Institute of Materia Medica who published during this period, 565 (12 per cent) had at least one defence-related collaboration.
Return to directoryNotes
All cited web content was viewed at its original website location; however, to ensure ongoing accessibility we are providing links to Internet Archive versions here.
- Baike Baidu. 2025. 'Tang Xican.' [唐希灿]. As of 8 April 2026.Return to content⤴
- Baike Baidu. 2025. 'Tang Xican.' [唐希灿]. As of 8 April 2026.Return to content⤴
- Baike Baidu. 2025. 'Tang Xican.' [唐希灿]. As of 8 April 2026.Return to content⤴